Cargando…
4-[1-(Substituted aryl/alkyl carbonyl)-benzoimidazol-2-yl]-benzenesulfonic acids: Synthesis, antimicrobial activity, QSAR studies, and antiviral evaluation
A series of 4-[1-(substituted aryl/alkyl carbonyl)-benzoimidazol-2-yl]-benzene sulphonic acids (1-20) was synthesized and evaluated, in vitro, for their antimicrobial activity and the results indicated that compounds 4-[1-(4-Nitrobenzoyl)-1H-benzoimidazol-2-yl]-benzenesulfonic acid (9) and 4-(1-octa...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115694/ https://www.ncbi.nlm.nih.gov/pubmed/20971531 http://dx.doi.org/10.1016/j.ejmech.2010.09.065 |
_version_ | 1783514150783156224 |
---|---|
author | Yadav, Snehlata Kumar, Pradeep De Clercq, Erik Balzarini, Jan Pannecouque, Christophe Dewan, Sharwan Kumar Narasimhan, Balasubramanian |
author_facet | Yadav, Snehlata Kumar, Pradeep De Clercq, Erik Balzarini, Jan Pannecouque, Christophe Dewan, Sharwan Kumar Narasimhan, Balasubramanian |
author_sort | Yadav, Snehlata |
collection | PubMed |
description | A series of 4-[1-(substituted aryl/alkyl carbonyl)-benzoimidazol-2-yl]-benzene sulphonic acids (1-20) was synthesized and evaluated, in vitro, for their antimicrobial activity and the results indicated that compounds 4-[1-(4-Nitrobenzoyl)-1H-benzoimidazol-2-yl]-benzenesulfonic acid (9) and 4-(1-octadec-9-enoyl-1H-benzoimidazol-2-yl)-benzenesulfonic acid (18) were found to be the most active ones. QSAR investigations indicated that the multi-target QSAR model was effective in describing the antimicrobial activity over the one-target QSAR models. Further the mt-QSAR model indicated the importance of the topological parameter, Balaban index (J) followed by the electronic parameter, LUMO and topological parameter, valence second order molecular connectivity index ((2)χ(v)) in describing the antimicrobial activity of synthesized compounds (1-20). |
format | Online Article Text |
id | pubmed-7115694 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71156942020-04-02 4-[1-(Substituted aryl/alkyl carbonyl)-benzoimidazol-2-yl]-benzenesulfonic acids: Synthesis, antimicrobial activity, QSAR studies, and antiviral evaluation Yadav, Snehlata Kumar, Pradeep De Clercq, Erik Balzarini, Jan Pannecouque, Christophe Dewan, Sharwan Kumar Narasimhan, Balasubramanian Eur J Med Chem Original Article A series of 4-[1-(substituted aryl/alkyl carbonyl)-benzoimidazol-2-yl]-benzene sulphonic acids (1-20) was synthesized and evaluated, in vitro, for their antimicrobial activity and the results indicated that compounds 4-[1-(4-Nitrobenzoyl)-1H-benzoimidazol-2-yl]-benzenesulfonic acid (9) and 4-(1-octadec-9-enoyl-1H-benzoimidazol-2-yl)-benzenesulfonic acid (18) were found to be the most active ones. QSAR investigations indicated that the multi-target QSAR model was effective in describing the antimicrobial activity over the one-target QSAR models. Further the mt-QSAR model indicated the importance of the topological parameter, Balaban index (J) followed by the electronic parameter, LUMO and topological parameter, valence second order molecular connectivity index ((2)χ(v)) in describing the antimicrobial activity of synthesized compounds (1-20). Elsevier Masson SAS. 2010-12 2010-10-07 /pmc/articles/PMC7115694/ /pubmed/20971531 http://dx.doi.org/10.1016/j.ejmech.2010.09.065 Text en Copyright © 2010 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Article Yadav, Snehlata Kumar, Pradeep De Clercq, Erik Balzarini, Jan Pannecouque, Christophe Dewan, Sharwan Kumar Narasimhan, Balasubramanian 4-[1-(Substituted aryl/alkyl carbonyl)-benzoimidazol-2-yl]-benzenesulfonic acids: Synthesis, antimicrobial activity, QSAR studies, and antiviral evaluation |
title | 4-[1-(Substituted aryl/alkyl carbonyl)-benzoimidazol-2-yl]-benzenesulfonic acids: Synthesis, antimicrobial activity, QSAR studies, and antiviral evaluation |
title_full | 4-[1-(Substituted aryl/alkyl carbonyl)-benzoimidazol-2-yl]-benzenesulfonic acids: Synthesis, antimicrobial activity, QSAR studies, and antiviral evaluation |
title_fullStr | 4-[1-(Substituted aryl/alkyl carbonyl)-benzoimidazol-2-yl]-benzenesulfonic acids: Synthesis, antimicrobial activity, QSAR studies, and antiviral evaluation |
title_full_unstemmed | 4-[1-(Substituted aryl/alkyl carbonyl)-benzoimidazol-2-yl]-benzenesulfonic acids: Synthesis, antimicrobial activity, QSAR studies, and antiviral evaluation |
title_short | 4-[1-(Substituted aryl/alkyl carbonyl)-benzoimidazol-2-yl]-benzenesulfonic acids: Synthesis, antimicrobial activity, QSAR studies, and antiviral evaluation |
title_sort | 4-[1-(substituted aryl/alkyl carbonyl)-benzoimidazol-2-yl]-benzenesulfonic acids: synthesis, antimicrobial activity, qsar studies, and antiviral evaluation |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115694/ https://www.ncbi.nlm.nih.gov/pubmed/20971531 http://dx.doi.org/10.1016/j.ejmech.2010.09.065 |
work_keys_str_mv | AT yadavsnehlata 41substitutedarylalkylcarbonylbenzoimidazol2ylbenzenesulfonicacidssynthesisantimicrobialactivityqsarstudiesandantiviralevaluation AT kumarpradeep 41substitutedarylalkylcarbonylbenzoimidazol2ylbenzenesulfonicacidssynthesisantimicrobialactivityqsarstudiesandantiviralevaluation AT declercqerik 41substitutedarylalkylcarbonylbenzoimidazol2ylbenzenesulfonicacidssynthesisantimicrobialactivityqsarstudiesandantiviralevaluation AT balzarinijan 41substitutedarylalkylcarbonylbenzoimidazol2ylbenzenesulfonicacidssynthesisantimicrobialactivityqsarstudiesandantiviralevaluation AT pannecouquechristophe 41substitutedarylalkylcarbonylbenzoimidazol2ylbenzenesulfonicacidssynthesisantimicrobialactivityqsarstudiesandantiviralevaluation AT dewansharwankumar 41substitutedarylalkylcarbonylbenzoimidazol2ylbenzenesulfonicacidssynthesisantimicrobialactivityqsarstudiesandantiviralevaluation AT narasimhanbalasubramanian 41substitutedarylalkylcarbonylbenzoimidazol2ylbenzenesulfonicacidssynthesisantimicrobialactivityqsarstudiesandantiviralevaluation |